Bottom line
How much do PRHSX and PHLAX overlap?
52% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 35.1% of PRHSX's assets and 48.2% of PHLAX's. They share a meaningful core but differ in the rest of the portfolio.
PRHSX holds far more positions (279 vs 55), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and PHLAX have in common
| Holding | % of PRHSX | % of PHLAX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 17.35% | 14.28% |
| Unitedhealth Group Inc | 5.99% | 5.87% | 5.87% |
| Merck & Co. Inc. | 4.01% | 6.06% | 4.01% |
| Thermo Fisher Scientific Inc | 2.52% | 4.56% | 2.52% |
| Vertex Pharmaceuticals Inc | 2.28% | 3.37% | 2.28% |
| Intuitive Surgical Inc | 1.87% | 3.07% | 1.87% |
| Stryker Corp | 1.78% | 2.16% | 1.78% |
| Danaher Corp | 1.43% | 3.28% | 1.43% |
| Cvs Health Corp | 0.94% | 2.52% | 0.94% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Johnson & Johnson — 6.63%
- Abbvie Inc — 5.10%
- Gilead Sciences Inc — 2.82%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
- Amgen Inc — 1.82%
- Elevance Health Inc — 1.53%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.23%
- Cardinal Health Inc — 1.03%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Only in PHLAX
- Argenx Se — 3.55%
- Lonza Group Ag — 3.02%
- (PIPA070) PGIM Core Government Money Market Fund — 2.50%
- Insmed Inc — 2.28%
- Roivant Sciences Ltd — 2.21%
- Sionna Therapeutics Inc — 2.01%
- Beone Medicines Ltd — 1.82%
- Vaxcyte Inc — 1.77%
- Align Technology Inc — 1.75%
- Agilent Technologies Inc — 1.73%
- Palvella Therapeutics Inc — 1.56%
- Apogee Therapeutics Inc — 1.42%
- Cabaletta Bio Inc — 1.35%
- Prudential Investment Portfolios 9 — 1.31%
- Newamsterdam Pharma Company Nv — 1.30%
Asset mix
| Asset type | PRHSX | PHLAX |
|---|---|---|
| Stocks | 96.4% | 97.8% |
| Cash & short-term funds | 0.7% | 3.8% |
| Preferred stock | 3.0% | — |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)
Country mix
| Country | PRHSX | PHLAX |
|---|---|---|
| US | 92.6% | 84.7% |
| NL | 1.0% | 5.4% |
| CH | 0.5% | 4.8% |
| BM | 0.7% | 2.2% |
| GB | 1.7% | 1.1% |
| CA | 0.6% | 1.0% |
| IL | 0.2% | 1.0% |
| DE | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)
Check another pair
FAQ
How much do PRHSX and PHLAX overlap?
What stocks do PRHSX and PHLAX have in common?
Should I own both PRHSX and PHLAX?
Which holds more stocks, PRHSX or PHLAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.